Centre François Baclesse-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2018

  1. Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

    Annals of Oncology, Vol. 29, Núm. 4, pp. 881-887

2011

  1. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study

    The Lancet, Vol. 377, Núm. 9769, pp. 914-923